ALIMERA SCIENCES, INC. Forms 3, 4 and 5: Stock Options
Statements of beneficial ownership filed with the SEC by officers, directors and 10% owners: 30 rows in 2013. Transaction codes are the SEC's. Shares and prices are split-adjusted; the as-filed figure is underneath.
- 2013-12-16: Reporting owner Myers C. Daniel; Form 4; Security Employee Stock Option (Right to Buy); Transaction A Grant, award or other acquisition pursuant to Rule 16b-3(d).
- 2013-12-16: Reporting owner Myers C. Daniel; Form 4; Security Employee Stock Option (Right to Buy); Transaction A Grant, award or other acquisition pursuant to Rule 16b-3(d).
- 2013-12-16: Reporting owner Holland David; Form 4; Security Employee Stock Option (Right to Buy); Transaction A Grant, award or other acquisition pursuant to Rule 16b-3(d).
- 2013-12-16: Reporting owner Holland David; Form 4; Security Employee Stock Option (Right to Buy); Transaction A Grant, award or other acquisition pursuant to Rule 16b-3(d).
| Transaction date | Reporting owner | Form | Security | Transaction | Shares | Price | Price that day | Filing |
|---|---|---|---|---|---|---|---|---|
| 2013-12-16 | Myers C. Daniel Director, Officer (President and CEO) | 4 | Employee Stock Option (Right to Buy) Derivative · Direct | A Grant, award or other acquisition pursuant to Rule 16b-3(d) | +365,000 365,000 owned after | $2.47 exercise price | 2013-12-18 | |
| 2013-12-16 | Myers C. Daniel Director, Officer (President and CEO) | 4 | Employee Stock Option (Right to Buy) Derivative · Direct | A Grant, award or other acquisition pursuant to Rule 16b-3(d) | +110,000 110,000 owned after | $2.47 exercise price | 2013-12-18 | |
| 2013-12-16 | Holland David Officer (SVP of Sales & Marketing) | 4 | Employee Stock Option (Right to Buy) Derivative · Direct | A Grant, award or other acquisition pursuant to Rule 16b-3(d) | +110,000 110,000 owned after | $2.47 exercise price | 2013-12-18 | |
| 2013-12-16 | Holland David Officer (SVP of Sales & Marketing) | 4 | Employee Stock Option (Right to Buy) Derivative · Direct | A Grant, award or other acquisition pursuant to Rule 16b-3(d) | +40,000 40,000 owned after | $2.47 exercise price | 2013-12-18 | |
| 2013-12-16 | Green Kenneth Officer (SVP & Chief Science Officer) | 4 | Employee Stock Option (Right to Buy) Derivative · Direct | A Grant, award or other acquisition pursuant to Rule 16b-3(d) | +135,000 135,000 owned after | $2.47 exercise price | 2013-12-18 | |
| 2013-12-16 | Green Kenneth Officer (SVP & Chief Science Officer) | 4 | Employee Stock Option (Right to Buy) Derivative · Direct | A Grant, award or other acquisition pursuant to Rule 16b-3(d) | +65,000 65,000 owned after | $2.47 exercise price | 2013-12-18 | |
| 2013-12-16 | EISWIRTH RICHARD S JR Officer (COO and CFO) | 4 | Employee Stock Option (Right to Buy) Derivative · Direct | A Grant, award or other acquisition pursuant to Rule 16b-3(d) | +235,000 235,000 owned after | $2.47 exercise price | 2013-12-18 | |
| 2013-12-16 | EISWIRTH RICHARD S JR Officer (COO and CFO) | 4 | Employee Stock Option (Right to Buy) Derivative · Direct | A Grant, award or other acquisition pursuant to Rule 16b-3(d) | +105,000 105,000 owned after | $2.47 exercise price | 2013-12-18 | |
| 2013-12-16 | Caballa Susan Officer (SVP,Regulatory&Medical Affairs) | 4 | Employee Stock Option (Right to Buy) Derivative · Direct | A Grant, award or other acquisition pursuant to Rule 16b-3(d) | +90,000 90,000 owned after | $2.47 exercise price | 2013-12-18 | |
| 2013-12-16 | Caballa Susan Officer (SVP,Regulatory&Medical Affairs) | 4 | Employee Stock Option (Right to Buy) Derivative · Direct | A Grant, award or other acquisition pursuant to Rule 16b-3(d) | +35,000 35,000 owned after | $2.47 exercise price | 2013-12-18 | |
| 2013-12-16 | Ashman Philip Officer (SVP, EU Managing Director) | 4 | Employee Stock Option (Right to Buy) Derivative · Direct | A Grant, award or other acquisition pursuant to Rule 16b-3(d) | +135,000 135,000 owned after | $2.47 exercise price | 2013-12-18 | |
| 2013-12-16 | Ashman Philip Officer (SVP, EU Managing Director) | 4 | Employee Stock Option (Right to Buy) Derivative · Direct | A Grant, award or other acquisition pursuant to Rule 16b-3(d) | +65,000 65,000 owned after | $2.47 exercise price | 2013-12-18 | |
| 2013-06-18 | Brooks Mark J Director, 10% Owner | 4 | Stock Option (Right to Buy) Derivative · Indirect · See Footnote | A Grant, award or other acquisition pursuant to Rule 16b-3(d) | +20,000 20,000 owned after | $5.39 exercise price | 2013-06-20 | |
| 2013-06-18 | BRADLEY GLEN Director | 4 | Stock Option (Right to Buy) Derivative · Direct | A Grant, award or other acquisition pursuant to Rule 16b-3(d) | +20,000 20,000 owned after | $5.39 exercise price | 2013-06-20 | |
| 2013-06-18 | Largent James R Director | 4 | Stock Option (Right to Buy) Derivative · Direct | A Grant, award or other acquisition pursuant to Rule 16b-3(d) | +20,000 20,000 owned after | $5.39 exercise price | 2013-06-20 | |
| 2013-06-18 | TRACY PHILIP R Director | 4 | Stock Option (Right to Buy) Derivative · Direct | A Grant, award or other acquisition pursuant to Rule 16b-3(d) | +20,000 20,000 owned after | $5.39 exercise price | 2013-06-20 | |
| 2013-06-18 | Kong Garheng Director, 10% Owner | 4 | Stock Option (Right to Buy) Derivative · Direct | A Grant, award or other acquisition pursuant to Rule 16b-3(d) | +20,000 20,000 owned after | $5.39 exercise price | 2013-06-20 | |
| 2013-06-18 | Roberts Calvin W. Director | 4 | Stock Option (Right to Buy) Derivative · Direct | A Grant, award or other acquisition pursuant to Rule 16b-3(d) | +20,000 20,000 owned after | $5.39 exercise price | 2013-06-20 | |
| 2013-06-18 | Pizzo Peter J. III Director | 4 | Stock Option (Right to Buy) Derivative · Direct | A Grant, award or other acquisition pursuant to Rule 16b-3(d) | +20,000 20,000 owned after | $5.39 exercise price | 2013-06-20 | |
| 2013-06-18 | Halak Brian K Director | 4 | Stock Option (Right to Buy) Derivative · Direct | A Grant, award or other acquisition pursuant to Rule 16b-3(d) | +20,000 20,000 owned after | $5.39 exercise price | 2013-06-19 | |
| 2013-02-21 holding as of filing | Kong Garheng Director, 10% Owner | 4/A | Stock Option (Right to Buy) Derivative · Direct | Holding | 0 owned after | no price filed | 2013-02-21 | |
| 2013-01-30 | Halak Brian K Director | 4 | Stock Option (Right to Buy) Derivative · Direct | A Grant, award or other acquisition pursuant to Rule 16b-3(d) | +12,500 12,500 owned after | $1.85 exercise price | 2013-02-01 | |
| 2013-01-30 | Brooks Mark J Director, 10% Owner | 4 | Stock Option (Right to Buy) Derivative · Indirect · See footnote | A Grant, award or other acquisition pursuant to Rule 16b-3(d) | +12,500 12,500 owned after | $1.85 exercise price | 2013-02-01 | |
| 2013-01-30 | BRADLEY GLEN Director | 4 | Stock Option (Right to Buy) Derivative · Direct | A Grant, award or other acquisition pursuant to Rule 16b-3(d) | +12,500 12,500 owned after | $1.85 exercise price | 2013-02-01 | |
| 2013-01-30 | Roberts Calvin W. Director | 4 | Stock Option (Right to Buy) Derivative · Direct | A Grant, award or other acquisition pursuant to Rule 16b-3(d) | +12,500 12,500 owned after | $1.85 exercise price | 2013-02-01 | |
| 2013-01-30 | Largent James R Director | 4 | Stock Option (Right to Buy) Derivative · Direct | A Grant, award or other acquisition pursuant to Rule 16b-3(d) | +12,500 12,500 owned after | $1.85 exercise price | 2013-02-01 | |
| 2013-01-30 | Kong Garheng Director, 10% Owner | 4 | Stock Option (Right to Buy) Derivative · Direct | A Grant, award or other acquisition pursuant to Rule 16b-3(d) | +12,500 12,500 owned after | $1.85 exercise price | 2013-02-01 | |
| 2013-01-30 | Pizzo Peter J. III Director | 4 | Stock Option (Right to Buy) Derivative · Direct | A Grant, award or other acquisition pursuant to Rule 16b-3(d) | +12,500 12,500 owned after | $1.85 exercise price | 2013-02-01 | |
| 2013-01-30 | TRACY PHILIP R Director | 4 | Stock Option (Right to Buy) Derivative · Direct | A Grant, award or other acquisition pursuant to Rule 16b-3(d) | +12,500 12,500 owned after | $1.85 exercise price | 2013-02-01 | |
| 2013-01-02 | Ashman Philip Officer (SVP, EU Managing Director) | 4 | Employee Stock Option (Right to Buy) Derivative · Direct | A Grant, award or other acquisition pursuant to Rule 16b-3(d) | +200,000 200,000 owned after | $1.63 exercise price | 2013-01-04 |